These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12480756)

  • 41. Effects of paraoxonase 1 activity and gene polymorphisms on long-term pulmonary complications of sulfur mustard-exposed veterans.
    Taravati A; Ardestani SK; Ziaee AA; Ghorbani A; Soroush MR; Faghihzadeh S; Kazemi H; Rezaei A; Hoseini H; Ghazanfari T
    Int Immunopharmacol; 2013 Nov; 17(3):974-9. PubMed ID: 23370296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-speed detection of the two common paraoxonase polymorphisms Leu55-->Met and Gln192-->Arg by real-time fluorescence PCR and melting curves.
    Harangi M; Aslanidis C; Paragh G; Schmitz G
    Clin Chem Lab Med; 2002 Apr; 40(4):337-40. PubMed ID: 12059071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: a meta-analysis.
    Pi Y; Zhang L; Chang K; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Neurosci Lett; 2012 Aug; 523(2):174-9. PubMed ID: 22776645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease.
    Carmine A; Buervenich S; Sydow O; Anvret M; Olson L
    Mov Disord; 2002 Jul; 17(4):764-6. PubMed ID: 12210872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of organophosphate intoxication on human serum paraoxonase.
    Sözmen EY; Mackness B; Sözmen B; Durrington P; Girgin FK; Aslan L; Mackness M
    Hum Exp Toxicol; 2002 May; 21(5):247-52. PubMed ID: 12141395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.
    Zhang B; Eto S; Fan P; Bian C; Shimoji E; Saito T; Saku K
    Clin Nephrol; 2003 Oct; 60(4):257-65. PubMed ID: 14579940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients.
    Hasselwander O; Savage DA; McMaster D; Loughrey CM; McNamee PT; Middleton D; Nicholls DP; Maxwell AP; Young IS
    Kidney Int; 1999 Jul; 56(1):289-98. PubMed ID: 10411705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations.
    Leviev I; James RW
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):516-21. PubMed ID: 10669651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paraoxonase gene polymorphism and the risk for Alzheimer's disease in the polish population.
    Klimkowicz-Mrowiec A; Marona M; Wolkow P; Witkowski A; Maruszak A; Styczynska M; Barcikowska M; Szczudlik A; Slowik A
    Dement Geriatr Cogn Disord; 2011; 31(6):417-23. PubMed ID: 21757906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between serum paraoxonase levels and carotid atherosclerotic plaque formation in Alzheimer's patients.
    Arslan A; Tüzün FA; Arslan H; Demir H; Tamer S; Demir C; Tasin M
    Neurol Neurochir Pol; 2016; 50(6):403-409. PubMed ID: 27546893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacogenomic considerations of the paraoxonase polymorphisms.
    Furlong CE; Cole TB; Jarvik GP; Costa LG
    Pharmacogenomics; 2002 May; 3(3):341-8. PubMed ID: 12052142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.
    Koch M; Hering S; Barth C; Ehren M; Enderle MD; Pfohl M
    Exp Clin Endocrinol Diabetes; 2001; 109(3):141-5. PubMed ID: 11409295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.
    Skoog I; Wallin A; Fredman P; Hesse C; Aevarsson O; Karlsson I; Gottfries CG; Blennow K
    Neurology; 1998 Apr; 50(4):966-71. PubMed ID: 9566380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke.
    Kölsch H; Linnebank M; Lütjohann D; Jessen F; Wüllner U; Harbrecht U; Thelen KM; Kreis M; Hentschel F; Schulz A; von Bergmann K; Maier W; Heun R
    Neurology; 2004 Dec; 63(12):2255-60. PubMed ID: 15623683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PON1-192 phenotype and genotype assessments in 918 subjects of the Stanislas cohort study.
    Vincent-Viry M; Sass C; Bastien S; Aguillon D; Siest G; Visvikis S
    Clin Chem Lab Med; 2003 Apr; 41(4):535-40. PubMed ID: 12747599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of cadmium, lead and mercury with paraoxonase 1 activity in women.
    Pollack AZ; Sjaarda L; Ahrens KA; Mumford SL; Browne RW; Wactawski-Wende J; Schisterman EF
    PLoS One; 2014; 9(3):e92152. PubMed ID: 24682159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia.
    Romani A; Trentini A; Flier WMV; Bellini T; Zuliani G; Cervellati C; Teunissen CE
    Antioxidants (Basel); 2020 May; 9(5):. PubMed ID: 32466344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.